VIR 280,000$ YOLO ahead of Phase 3 results
$VIR
AI SUMMARY — User is making a large $280,000 bet on Vir Biotechnology ahead of Phase 3 clinical trial results, betting on positive outcomes that could drive stock appreciation. Key risks include trial failure, regulatory setbacks, and binary event risk typical of biotech companies awaiting major clinical announcements.
| TICKER | VIR |
USER | u/ElectricalJeweler587 |
| RATING |
BULLISH |
ENTRY |
$10.47
|
| POSITION |
955 sh
SYN
|
BOOK VAL |
$10000.00 |
| CURRENT |
$10.47 |
P&L % |
+0.00%
|
| CURR VAL |
$10000.00 |
P&L $ |
+0.00
|